|Mr. John G. Melo||Pres, CEO & Director||1.8M||N/A||1966|
|Ms. Kathleen Valiasek||Chief Financial Officer||615.47k||N/A||1964|
|Mr. Eduardo Alvarez||Chief Operating Officer||534.26k||N/A||1964|
|Ms. Nicole Kelsey||Gen. Counsel & Sec.||704.16k||N/A||1967|
|Dr. Joel R. Cherry||Pres of R&D||N/A||N/A||1961|
Amyris, Inc., an integrated renewable products company, engages in the research, development, and production of ingredients for the health and wellness, clean beauty, and flavors and fragrances markets worldwide. It applies its bioscience solutions to convert plant sugars into hydrocarbon molecules and produce specialty ingredients and consumer products. The company delivers its products and services under the No Compromise name across various markets, including specialty and performance chemicals, flavors and fragrances, cosmetics ingredients, pharmaceuticals, and nutraceuticals. It has a collaboration agreement with Yifan Pharmaceutical Co., Ltd. and Givaudan SA. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010. Amyris, Inc. was founded in 2003 and is headquartered in Emeryville, California.
Amyris, Inc.’s ISS Governance QualityScore as of January 1, 2019 is 10. The pillar scores are Audit: 10; Board: 8; Shareholder Rights: 7; Compensation: 9.